KK
AKRO

KLP Kapitalforvaltning’s Akero Therapeutics AKRO Stock Holding History

KLP Kapitalforvaltning’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,800
Closed -$560K – 2171
2025
Q3 		$560K Hold
11,800
– – ﹤0.01% 1339
2025
Q2 		$630K Buy
11,800
+2,200
+23% +$100K ﹤0.01% 1235
2025
Q1 		$389K Sell
9,600
-1,400
-13% -$59.3K ﹤0.01% 1435
2024
Q4 		$306K Buy
+11,000
New +$333K ﹤0.01% 1635

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

KLP Kapitalforvaltning's AKRO Position: Q4 2025 in Review

KLP Kapitalforvaltning sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 11,800 shares — an estimated $560K sold.

KLP Kapitalforvaltning first reported a position in AKRO in Q4 2024 and held it in 4 quarters. The position peaked at $630K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • KLP Kapitalforvaltning reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • KLP Kapitalforvaltning sold 11,800 Akero Therapeutics shares in Q4 2025, an estimated $560K.
  • KLP Kapitalforvaltning first reported a position in Akero Therapeutics in Q4 2024 and held it in 4 quarters.
  • KLP Kapitalforvaltning's Akero Therapeutics position peaked at $630K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on KLP Kapitalforvaltning's 13F filing for Q4 2025, filed 28 Jan 2026.